The company raised $36 million in an oversubscribed series C financing with the help of Israel-U.S. investors, according to a March 30 news release. The series C financing comes eight months after Augmedics closed a $21 million series B financing. The total funding is now $63 million.
Augmedics creates augmented reality surgical imaging guidance. Its Xvision system has been used by spine surgeons across the U.S.
More articles on devices:
Spinal fusion ‘picking up steam’ at ASCs: 2 leaders discuss practice growth
Alphatec, NuVasive & SeaSpine: Key spine acquisitions in 2021
Why endoscopic spine surgery in the US lags behind Europe, Asia
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.